OneDigital Investment Advisors LLC Acquires 1,946 Shares of Stryker Corporation (NYSE:SYK)

OneDigital Investment Advisors LLC boosted its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 8.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,655 shares of the medical technology company's stock after acquiring an additional 1,946 shares during the quarter. OneDigital Investment Advisors LLC's holdings in Stryker were worth $9,178,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Mascoma Wealth Management LLC lifted its holdings in Stryker by 22.7% in the 4th quarter. Mascoma Wealth Management LLC now owns 146 shares of the medical technology company's stock valued at $53,000 after acquiring an additional 27 shares during the last quarter. Lindbrook Capital LLC lifted its stake in shares of Stryker by 2.0% in the 4th quarter. Lindbrook Capital LLC now owns 1,407 shares of the medical technology company's stock valued at $507,000 after purchasing an additional 28 shares during the last quarter. Continuum Advisory LLC boosted its stake in shares of Stryker by 5.8% during the 1st quarter. Continuum Advisory LLC now owns 532 shares of the medical technology company's stock worth $198,000 after acquiring an additional 29 shares in the last quarter. Oakworth Capital Inc. increased its holdings in shares of Stryker by 0.5% during the 1st quarter. Oakworth Capital Inc. now owns 6,133 shares of the medical technology company's stock valued at $2,283,000 after acquiring an additional 29 shares during the last quarter. Finally, United Community Bank raised its position in shares of Stryker by 3.4% in the fourth quarter. United Community Bank now owns 904 shares of the medical technology company's stock valued at $325,000 after purchasing an additional 30 shares during the period. Institutional investors own 77.09% of the company's stock.

Stryker Price Performance

Shares of NYSE SYK traded up $0.19 during mid-day trading on Friday, hitting $392.00. 536,295 shares of the stock were exchanged, compared to its average volume of 1,346,875. Stryker Corporation has a twelve month low of $314.93 and a twelve month high of $406.19. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. The stock's fifty day simple moving average is $382.92 and its two-hundred day simple moving average is $376.13. The company has a market cap of $149.62 billion, a P/E ratio of 52.97, a PEG ratio of 2.98 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. The firm had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The business's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.50 earnings per share. As a group, analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. Stryker's dividend payout ratio (DPR) is 45.41%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Truist Financial lifted their price target on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research report on Monday, May 5th. Citigroup reaffirmed a "buy" rating and set a $455.00 target price (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a report on Monday, May 5th. Roth Mkm upped their price objective on shares of Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. Finally, JMP Securities reissued a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $427.30.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 5.90% of the stock is currently owned by corporate insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.